DUNTON ALAN W 4
4 · CorMedix Inc. · Filed Sep 16, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
DUNTON ALAN W
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-09-12−10,000→ 20,000 totalExercise: $3.55Exp: 2034-03-05→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2025-09-12$3.55/sh+10,000$35,500→ 50,250 total - Sale
Common Stock
2025-09-12$13.13/sh−10,000$131,300→ 40,250 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $13.00 to $13.25. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.